Merck to Report Q3 Earnings: To Buy or Not to Buy MRK Stock?

Merck (MRK) will report its third-quarter earnings on Oct. 31, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $16.54 billion and$1.54 per share, respectively. Earnings estimates for Merck have declined from $8.01 to$7.80 per share over the past 30 days. For 2025, earnings estimates have declined from $9.70 to$9.64 per share over the same timeframe.Image Source: Zacks Investment ResearchEarnings Surprise History of MerckThe healthcare bellwether’s performance has been ...